Season
1
Subscribe and enjoy the content, wherever and whenever you want
Prof. Dr. Federico Martinón-Torres
Prof. Dr. Federico Martinón Torres
Head of pediatrics department Hospital Clínico Universitario de Santiago, Spain.
Genetics, Vaccines, Infections and Pediatrics Research Group (GENVIP-www.genvip.org)
Instituto de Investigación Sanitaria de Santiago
Introduction

Presentation

Without doubt, this year is atypical – but we don’t want to remember the negative stuff only. We are reinventing TIPiCO and turning it into aTIPiCO, which will be atypical but also special. A high-level series with great scientific impact, in downloadable episodes which can be watched anytime, anywhere. The impossibility of meeting at Santiago de Compostela like every year, seeing each other, sharing experiences, enjoying the town and interacting in person with speakers and other experts poses a great challenge. But we will rise to it. Again, we have brought together the world’s top experts in infectious diseases and vaccines. We will rely on their experience, their knowledge and their research to better undersand where we stand, and what we can do in order to beat this pandemic. We will talk about SARS-CoV-2 and vaccines against COVID-19 with the researchers themselves, but also about other infections and vaccines, despite COVID-19, and the essential lessons they provide. aTIPiCO wants to learn from those who have brought us to where we are in desease prevention – we are confident that they will lead us out of this pandemic too.
Federico Martinón-Torres
Signature Prof. Dr. Federico Martinón-Torres
Our main characters

Protagonists

Speaker Prof. Dr. James D. Cherry

Prof. Dr. James D. Cherry

UCLA Mattel Children's Hospital
United States of America
Speaker Prof. Xavi Bosch

Prof. Xavi Bosch

Institut Catalá de Oncología, Spain
Spain
Speaker Prof. Adolfo García-Sastre

Prof. Adolfo García-Sastre

Mount Sinai-NY University
United States of America
Speaker Dr. Jose Gómez Rial

Dr. Jose Gómez Rial

Hospital Clinico Universitario deSantiago de Compostela
Spain
Speaker Prof. Michael J. Mina

Prof. Michael J. Mina

Harvard Medical School, Boston
United States od America
Speaker Prof. Dr. Shamez Ladhani

Prof. Dr. Shamez Ladhani

Public Health England
United Kingdom
Speaker Prof. Dr. Carlos Martín Montañés

Prof. Dr. Carlos Martín Montañés

Universidad de Zaragoza
Spain
Speaker Prof. Dr. Federico Martinón-Torres

Prof. Dr. Federico Martinón-Torres

University of Santiago
Spain
Speaker Porf. Dr. Ab Osterhaus

Porf. Dr. Ab Osterhaus

Research Center for Emerging Infections and Zoonoses
Germany
Speaker Prof. Dr. Octavio Ramilo

Prof. Dr. Octavio Ramilo

Ohio State University College of Medicine
United States of America
Speaker Dr. Tamara Pilishvili

Dr. Tamara Pilishvili

Centre for Disease Control and Prevention
United States of America
Speaker Prof. Andrew Pollard

Prof. Andrew Pollard

University of Oxford
United Kingdom
Speaker Prof. Antonio Salas Ellacuriaga

Prof. Antonio Salas Ellacuriaga

Universidad de Santiago de Compostela
Spain
Chapters

Chapters

0 Chapter
Chapter 0

What to expect from Atípico: the director's cut

Speaker Prof. Federico Martinón-Torres
Prof. Federico Martinón-Torres
University of Santiago, Spain
Speaker Dr. Jose Gómez Rial
Dr. Jose Gómez Rial
H. Clinico Universitario de Santiago de Compostela, Spain
+
If you want to know what to expect fromthis year’s TIPICO edition, this is yourepisode. aTIPICO explained by its director.
1 Chapter
Chapter 1

PERTUSSIS AND MEASLES, THE LESSONS IN FRONT OF OUR EYES

Speaker Prof. Dr. James D. Cherry
Prof. Dr. James D. Cherry
UCLA Matter Children's Hospital, US
+
Whooping cough and measles are still a problem, but not the problem they used to be before vaccines were available. Several lessons can be learned that could not only improve what we do about measles or whooping cough, but will also help us in our fight against COVID-19. We will discuss this matter with the international authority on infectious diseases, Prof. James Cherry.
2 Chapter
Chapter 2

TUBERCULOSIS VACCINE AND BEYOND. FROMMTBVAC TO COVID-19 PROTECTION

Speaker Prof. Dr. Carlos Martín Montañés
Prof. Dr. Carlos Martín Montañés
University of Zaragoza, Spain
+
Vaccines against tuberculosis are now in vogue. Not only because they are sorely needed, but because of their possible role in preventing COVID-19. Prof. Carlos Martín, the “father” of the next generation live attenuated tuberculosis vaccine, MTBVAC, will discuss with us where we are and what we can expect.
3 Chapter
Chapter 3

DOES FLU (AND FLU EXPERTS) MATTER ANYMORE NOW WE HAVE COVID-19?

Speaker Prof. Dr. Ab Osterhaus
Prof. Dr. Ab Osterhaus
Research Centre of Hannover, Germany
+
Now that everything circles around COVID-19, that even the data from the southern hemisphere shows a surprisingly mild flu season, we might think that flu is no longer a problem anymore.But we better ask the oracle, and Ab Osterhaus can indeed answer us any question regarding flu, SARS-CoV-2 and any other viruses.
4 Chapter
Chapter 4

BACTERIAL INFECTIONS AND COVID-19: FRIENDS,FOES, OR WE JUST DON’T KNOW?

Speaker Prof. Dr. Shamez Ladhani
Prof. Dr. Shamez Ladhani
Public Health England, UK
+
Meningococcal or pneumococcal infections are life-threatening bacterial infections with currently available safe and effective vaccines. But the target is moving: we don’t know how COVID-19 can affect other vaccine-preventable diseases in general, and meningococcal or pneumococcal infection in particular. Shamez Ladhani will tell us about the UK experience,
5 Chapter
Chapter 5

CAN RSV TEACH US SOMETHING ABOUT COVID-19?

Speaker Prof. Dr. Octavio Ramilo
Prof. Dr. Octavio Ramilo
Ohio State University College of Medicine, US
+
Yes, RSV is not gone, and it has been a difficult target for vaccines for decades. Several lessons can be learnt from what we have done during all of these years to tackle RSV. Talking with one of the world leads in this arena, Octavio Ramilo, will enlighten us.
6 Chapter
Chapter 6

CAN GENETICS HELP AGAINST COVID-19?

Speaker Prof. Antonio Salas Ellacuriaga
Prof. Antonio Salas Ellacuriaga
University of Santiago de Compostela, Spain
Speaker Dr. Jose Gómez Rial
Dr. Jose Gómez Rial
H. Clinico Universitario de Santiago de Compostela, Spain
Speaker Prof. Federico Martinón-Torres
Prof. Federico Martinón-Torres
University of Santiago, Spain
+
COVID-19 is an infectious disease that has changed the world. Only science can bring us back our normality. Federico Martinón-Torres will be discussing with the members of his team the possibilities that omics can offer in the fight against COVID-19. Prof. Salas as an expert in population genetics who will show us the tricks that can help us understand pandemics and Prof. Gomez-Rial will translate to us the deep immunological insights of SARS-COV-2.
7 Chapter
Chapter 7

HPV VACCINATION AND COVID-19 VACCINATION: LESSONS TO BECONSIDERED

Speaker Prof. Dr. Xavi Bosch
Prof. Dr. Xavi Bosch
Institut Catalá de Oncología, Spain
+
The opportunities and challenges that HPV vaccination has meant and still means for the story of vaccination is an important mirror to look at when talking about COVID-19 vaccines implementation. The experience of a privileged mentor and witness throughout the process,Xavi Bosch, brings us a unique opportunity for us to listen and learn. Federico Martinón-Torres will discuss with him where we are withHPV vaccination and where we don’t want to be with COVID-19 vaccines implementation.
8 Chapter
Chapter 8

PNEUMOCOCCAL VACCINATION BEYOND CHILDREN IN THE ERA OF CONJUGATE VACCINES

Speaker Dr. Tamara Pilishvili
Dr. Tamara Pilishvili
Centre for Disease Control and Prevention, US
+
The US has led the adulthood immunization schedule in many aspects. The introduction of conjugate pneumococcal vaccination in adults brought about a significant change. We are privileged to have Tamara Pilishvili from the US Center for Disease and Control to update us on the rationale and results of this strategy. We will also discuss adult vaccination in the framework of COVID-19.
9 Chapter
Chapter 9

RETHINKING STRATEGIES FROM COVID-19 DIAGNOSIS TO CLASSICAL VACCINES USE

Speaker Prof. Michael J. Mina
Prof. Michael J. Mina
Harvard Medical School, Boston, US
+
When we discuss about the heterologous effects of measles vaccines, Michael J. Mina is the man behind the science to support how this works, prompting new insigths about a classical disease and the role of measles vaccine in the prevention of “immune amnesia”.But the rethinking provoked by Michael is now over the table when we speak about COVID-19 diagnosis. These things and others will be discussed.
10 Chapter
Chapter 10

A VACCINE AGAINST COVID-19 – DO WE MEET AT OXFORD OR AT NEW YORK?

Speaker Prof. Andrew Pollard
Prof. Andrew Pollard
University of Oxford, UK
Speaker Prof. Adolfo García-Sastre
Prof. Adolfo García-Sastre
Mount Sinai-NY University, US
+
Two of the world leaders in the fight against COVID -19, Andy Pollard (Oxford, UK) and Adolfo García-Sastre (NYC, US) will discuss with Federico Martinón-Torres where we are in the race to obtain a vaccine against COVID-19 and what can we expect from the first generation of vaccines.
Simple pricing

Reserve your place

Ticket
Free
0 €
Limited access: you will be able to watch every chapter, only the day of its premiere (without the posibility of viewing previous chapters once the premiere date has passed).
Access to all chapters of the series and download podcast wherever and whenever you want
Enjoy the content, wherever and whenever you want
Ticket
Subscribe for just
99,50 €
Immediate access to all 10 chapters of the series
Podcast downloads
-50% for members of IDIS, REGALIP, RECLIP
Endorsed by
Sponsors